The US has an untapped opportunity to offer global leadership against drug resistance through the major global health programs it already supports, namely PEPFAR, the Global Fund, and the Presidents Malaria Imitative. In this memo, Victoria Fan and Amanda Glassman highlight considerations for Congress with respect to oversight of these key channels of US development assistance for health that greatly affect drug resistance.
This memo draws from a 2010 CGD working group report on The Race Against Drug Resistance, and was submitted to members of the House Foreign Affairs subcommittee on African and Global Health in advance of a 2013 hearing on drug-resistance in developing countries. The CGD report and its recommendations were referenced by Rep. Karen Bass (D-CA) during opening statements.
Rights & Permissions
You may use and disseminate CGD’s publications under these conditions.